C
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K286.6 KBCHIMERIX INCApr 21, 4:16 PM ET·0001193125-25-087237
- 10-K/A738.0 KBCHIMERIX INCApr 16, 4:10 PM ET·0001104659-25-035504
- 10-K12.0 MBCHIMERIX INCMar 21, 6:35 AM ET·0001117480-25-000004
- 8-K272.9 KBCHIMERIX INCMar 21, 6:06 AM ET·0001117480-25-000003
- 8-K/A887.7 KBCHIMERIX INCMar 5, 4:15 PM ET·0001104659-25-020884
- 8-K987.3 KBCHIMERIX INCMar 5, 7:03 AM ET·0001104659-25-020599
- 8-K199.2 KBCHIMERIX INCMar 3, 8:00 AM ET·0001104659-25-019497
- 8-K209.7 KBCHIMERIX INCDec 30, 7:21 AM ET·0001104659-24-132270
- 8-K6.2 MBCHIMERIX INCDec 10, 8:49 AM ET·0001117480-24-000039
- 8-K421.1 KBCHIMERIX INCNov 14, 4:20 PM ET·0001117480-24-000037
Insiders
10- Alrutz Michael AlbertSVP AND GENERAL COUNSEL
- Andriole Michael T.Director, PRESIDENT AND CEO
- Berrey M MichelleChief Medical Officer
- Canaan Partners VII LLCDirector, 10% Owner
- Canaan VII LPDirector, 10% Owner
- CANTEX PHARMACEUTICALS, INC.10% Owner
- Chambon Philippe O.10% Owner
- CHAMPSI FARAHDirector
- Daly James MDirector
- Decker Lisa LynnDirector
Tickers
No tickers on record
Addresses
business
2505 MERIDIAN PARKWAY, SUITE 100
DURHAM, NC, 27713
mailing
2505 MERIDIAN PARKWAY, SUITE 100
DURHAM, NC, 27713